BMJ Best Practice

参考文献

关键文献

Bunker CB. Dermatoses of male genitalia. In: Burns T, Breathnach S, Bleiker T, et al, eds. Rook’s textbook of dermatology. 9th ed. New York, NY: Wiley-Blackwel; 2014.

Edwards S, Bunker C, Ziller F, et al. 2013 European guideline for the management of balanoposthitis. Int J STD AIDS. 2014;25:615-626.

Bunker CB. Diseases and disorders of the male genitalia. In: Fitzpatrick's dermatology in general medicine. New York, NY: McGraw-Hill; 2003: Chapter 3.

参考文章

1.  Bunker CB. Dermatoses of male genitalia. In: Burns T, Breathnach S, Bleiker T, et al, eds. Rook’s textbook of dermatology. 9th ed. New York, NY: Wiley-Blackwel; 2014.

2.  Edwards S, Bunker C, Ziller F, et al. 2013 European guideline for the management of balanoposthitis. Int J STD AIDS. 2014;25:615-626.

3.  English JC, Laws RA, Keough GC, et al. Dermatoses of the glans penis and prepuce. J Am Acad Dermatol. 1997;37:1-24.

4.  Wakatsuki A. Clinical experience of streptococcal balanoposthitis in 47 healthy adult males. Hinyokika Kiyo. 2005;51:737-740.

5.  Cusano F, Capozzi M. Photocontact dermatitis from ketoprofen with cross-reactivity to ibuproxam. Contact Dermatitis. 1992;27:50-59.

6.  Lyon CC, Kulkarni J, Zimerson E, et al. Skin disorders in amputees. J Am Acad Derm. 2000;42:501-507.

7.  Gamulka BD. Index of suspicion. Case #1. Diagnosis: allergic contact dermatitis. Pediatr Rev. 2000;21:421-426.

8.  Ramam M, Khaitan BK, Singh MK, et al. Frictional sweat dermatitis. Contact Dermatitis. 1998;38:49.

9.  Jacobson MA. Review of the toxicities of foscarnet. J Acquir Immune Defic Syndr. 1992;5:11-17.

10.  Birley HDL, Walker MM, Luzzi GA, et al. Clinical features and management of recurrent balanitis; association with atopy and genital washing. Genitourin Med. 1993;69:400-403.

11.  Reiter H. Ueber eine bisher unerkannte. Dtsch Med Woschensch. 1916;42:1535-1536.

12.  Ridley CM. Lichen sclerosus et atrophicus. Br Med J (Clin Res Ed). 1987;295:1295-1296.

13.  Meffert JJ, Davis BM, Grimwood. Lichen sclerosus. J Am Acad Dermatol. 1995;32:393-416.

14.  Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet. 1999;22:1777-1783.

15.  Bunker CB. Diseases and disorders of the male genitalia. In: Fitzpatrick's dermatology in general medicine. New York, NY: McGraw-Hill; 2003: Chapter 3.

16.  Riddell L, Edwards A, Sherrard J. Clinical features of lichen sclerosus in men attending a department of genitourinary medicine. Sex Transm Infect. 2000;76:311-313.

17.  Pelisse M. Lichen sclerosus. Ann Dermatol Venereol. 1987;114:411-419.

18.  Feldmann R, Harms M. Lichen sclerosus et atrophicus. Hautarzt. 1991;42:147-153.

19.  Datta C, Dutta SK, Chaudhuri A. Histopathological and immunological studies in a cohort of balanitis xerotica obliterans. J Indian Med Assoc. 1993;91:146-148.

20.  Bunker CB. Topics in penile dermatology. Clin Exp Dermatol. 2001;26:469-479.

21.  Edmonds EV, Hunt S, Hawkins D, et al. Clinical parameters in male genital lichen sclerosus: a case series of 329 patients. J Eur Acad Dermatol Venereol. 2012;26:730-737.

22.  Edmonds EV, Oyama N, Chan I, et al. Extracellular matrix protein 1 autoantibodies in male genital lichen sclerosus. Br J Dermatol. 2011;165:218-219.

23.  Edmonds EV, Bunker CB. Nuclear magnetic resonance spectroscopy of urine in male genital lichen sclerosus. Br J Dermatol. 2010;163:1355-1356.

24.  Bunker CB, Patel N, Shim TN. Urinary voiding symptomatology (micro-incontinence) in male genital lichen sclerosus. Acta Derm Venereol. 2013;93:246-248.

25.  Edmonds E, Barton G, Buisson S, et al. Gene expression profiling in male genital lichen sclerosus. Int J Exp Pathol. 2011;92:320-325.

26.  Zoon JJ. Balanoposthite chronique cironscrite benigne a plasmocytes. Dermatologica. 1952;105:1-7.

27.  Zoon JJ. Verenigingsverslagen. Ned Tijdschr Geneeskd. 1950;94:1528-1530.

28.  Altmeyer P, Kastner U, Luther H. Balanitis/balanoposthitis chronica circumscripta benigna plasmacellularis - entity or fiction? Hautarzt. 1998;49:552-555.

29.  Bunker CB. Review of dermatology journals. Sex Transm Infect. 1999;75:281-282.

30.  Yoganathan S, Bohl TG, Mason G. Plasma cell balanitis and vulvitis (of Zoon). J Reprod Med. 1994;39:939-944.

31.  Kiene P, Folster-Holst R. No evidence of human papillomavirus infection in balanitis circumscripta plasmacellularis Zoon. Acta Derm Venereol. 1995;75:496-497.

32.  Catterall RD. In: Winner HL, Hurley R, eds. Symposium on candida infections. Edinburgh, UK: Livingstone; 1966:113.

33.  Odds FC. Genital candidiasis. Clin Exp Dermatol. 1982;7:345-354.

34.  Bunker CB. Re: Malignant and premalignant lesions of the penis. BMJ. 2013;346:f1149.

35.  Bunker CB. Malignant and premalignant lesions of the penis: penile cancer can be prevented or treated pre-emptively. BMJ. 2013;346:f2129.

36.  Eisendle K, Grabner T, Kutzner H, et al. Possible role of Borrelia burgdorferi sensu lato infection in lichen sclerosus. Arch Dermatol. 2008;144:591-598.

37.  Morris BJ, Krieger JN. Penile inflammatory skin disorders and the preventive role of circumcision. Int J Prev Med. 2017;8:32.

38.  Mallon E, Hawkins D, Dinneen M, et al. Circumcision and genital dermatoses. Arch Dermatol. 2000;136:350-354.

39.  Morris BJ. Why circumcision is a biomedical imperative for the 21st century. Bioessays. 2007;29:1147-1158.

40.  Doiron PR, Bunker CB. Obesity-related male genital lichen sclerosus. J Eur Acad Dermatol Venereol. 2017;31(5):876-879.

41.  Kmietowicz Z. Boys in England to get HPV vaccine from next year. BMJ 2018;362:k3237

42.  Centers for Disease Control and Prevention. HPV vaccines: vaccinating your preteen or teen. 2018. https://www.cdc.gov/

43.  Rao A, Bunker CB. Male genital skin biopsy. Int J STD AIDS. 2011;22:418-419.

44.  Bunker CB, Shim TN. Male genital lichen sclerosus. Indian J Dermatol. 2015;60:111-117.

45.  Bauer A, Geier J, Elsner P. Allergic contact dermatitis in patients with anogenital complaints. J Repro Med. 2000;45:649-654.

46.  Bunker CB. Re: Sanjay Kulkarni, Guido Barbagli, Deepak Kirpekar, et al. Lichen sclerosus of the male genitalia and urethra: surgical options and results in a multicenter international experience with 215 patients. Eur Urol 2009;55:945-56. Eur Urol. 2010;58:e55-e56.

47.  Kravvas G, Shim TN, Doiron PR, et al. The diagnosis and management of male genital lichen sclerosus: a retrospective review of 301 patients. J Eur Acad Dermatol Venereol. 2018;32(1):91-95.

48.  Lewis FM, Tatnall FM, Velangi SS, et al. British Association of Dermatologists' guidelines for the management of lichen sclerosus 2018. Br J Dermatol. 2018;178:839-853.

49.  Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1-137.

50.  Bunker CB, Neill S, Staughton RC. Topical tacrolimus, genital lichen sclerosus, and risk of squamous cell carcinoma. Arch Dermatol. 2004;140:1169.

51.  Bunker CB. Male genital lichen sclerosus and tacrolimus. Br J Dermatol. 2007;157:1079-1080.

52.  Kidd LC, Chaing S, Chipollini J et al. Relationship between human papillomavirus and penile cancer—implications for prevention and treatment. Transl Androl Urol. 2017;6(5):791–802.

53.  Doiron PR, Bunker CB. Expanding the benefits of HPV vaccination to boys and men. Lancet. 2016;388:659.

使用此内容应接受我们的免责声明